English
简体中文
Total: £ 56.28
Published Date: 2025-11-05 | Pages: 122 | Tables: 116 | Medical Care
The global Multiomics market is projected to grow from US$ 2835 million in 2024 to US$ 6124 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Multiomics is a new approach where the data sets of different omic groups are combined during analysis. The different omic strategies employed during multiomics are genome, proteome, transcriptome, epigenome, and microbiome.
Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Multiomics market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
BD
Thermo Fisher Scientific, Inc.
Illumina, Inc
Danaher (Beckman Coulter)
PerkinElmer, Inc
Shimadzu Corporation
Bruker
QIAGEN
Agilent Technologies, Inc.
BGI Genomics
Segment by Type
Single-cell Multiomics
Bulk Multiomics
Segment by Application
Cell Biology
Oncology
Neurology
Immunology
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Multiomics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Multiomics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Multiomics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Single-cell Multiomics
1.2.3 Bulk Multiomics
1.3 Market Segmentation by Application
1.3.1 Global Multiomics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cell Biology
1.3.3 Oncology
1.3.4 Neurology
1.3.5 Immunology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Multiomics Revenue Estimates and Forecasts 2020-2031
2.2 Global Multiomics Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Multiomics Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Multiomics Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Single-cell Multiomics Market Size by Players
3.3.2 Bulk Multiomics Market Size by Players
3.4 Global Multiomics Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Multiomics Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Multiomics Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Multiomics Market Size by Type (2020-2031)
6.4 North America Multiomics Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Multiomics Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Multiomics Market Size by Type (2020-2031)
7.4 Europe Multiomics Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Multiomics Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Multiomics Market Size by Type (2020-2031)
8.4 Asia-Pacific Multiomics Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Multiomics Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Multiomics Market Size by Type (2020-2031)
9.4 Central and South America Multiomics Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Multiomics Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Multiomics Market Size by Type (2020-2031)
10.4 Middle East and Africa Multiomics Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Multiomics Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 BD
11.1.1 BD Corporation Information
11.1.2 BD Business Overview
11.1.3 BD Multiomics Product Features and Attributes
11.1.4 BD Multiomics Revenue and Gross Margin (2020-2025)
11.1.5 BD Multiomics Revenue by Product in 2024
11.1.6 BD Multiomics Revenue by Application in 2024
11.1.7 BD Multiomics Revenue by Geographic Area in 2024
11.1.8 BD Multiomics SWOT Analysis
11.1.9 BD Recent Developments
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Corporation Information
11.2.2 Thermo Fisher Scientific, Inc. Business Overview
11.2.3 Thermo Fisher Scientific, Inc. Multiomics Product Features and Attributes
11.2.4 Thermo Fisher Scientific, Inc. Multiomics Revenue and Gross Margin (2020-2025)
11.2.5 Thermo Fisher Scientific, Inc. Multiomics Revenue by Product in 2024
11.2.6 Thermo Fisher Scientific, Inc. Multiomics Revenue by Application in 2024
11.2.7 Thermo Fisher Scientific, Inc. Multiomics Revenue by Geographic Area in 2024
11.2.8 Thermo Fisher Scientific, Inc. Multiomics SWOT Analysis
11.2.9 Thermo Fisher Scientific, Inc. Recent Developments
11.3 Illumina, Inc
11.3.1 Illumina, Inc Corporation Information
11.3.2 Illumina, Inc Business Overview
11.3.3 Illumina, Inc Multiomics Product Features and Attributes
11.3.4 Illumina, Inc Multiomics Revenue and Gross Margin (2020-2025)
11.3.5 Illumina, Inc Multiomics Revenue by Product in 2024
11.3.6 Illumina, Inc Multiomics Revenue by Application in 2024
11.3.7 Illumina, Inc Multiomics Revenue by Geographic Area in 2024
11.3.8 Illumina, Inc Multiomics SWOT Analysis
11.3.9 Illumina, Inc Recent Developments
11.4 Danaher (Beckman Coulter)
11.4.1 Danaher (Beckman Coulter) Corporation Information
11.4.2 Danaher (Beckman Coulter) Business Overview
11.4.3 Danaher (Beckman Coulter) Multiomics Product Features and Attributes
11.4.4 Danaher (Beckman Coulter) Multiomics Revenue and Gross Margin (2020-2025)
11.4.5 Danaher (Beckman Coulter) Multiomics Revenue by Product in 2024
11.4.6 Danaher (Beckman Coulter) Multiomics Revenue by Application in 2024
11.4.7 Danaher (Beckman Coulter) Multiomics Revenue by Geographic Area in 2024
11.4.8 Danaher (Beckman Coulter) Multiomics SWOT Analysis
11.4.9 Danaher (Beckman Coulter) Recent Developments
11.5 PerkinElmer, Inc
11.5.1 PerkinElmer, Inc Corporation Information
11.5.2 PerkinElmer, Inc Business Overview
11.5.3 PerkinElmer, Inc Multiomics Product Features and Attributes
11.5.4 PerkinElmer, Inc Multiomics Revenue and Gross Margin (2020-2025)
11.5.5 PerkinElmer, Inc Multiomics Revenue by Product in 2024
11.5.6 PerkinElmer, Inc Multiomics Revenue by Application in 2024
11.5.7 PerkinElmer, Inc Multiomics Revenue by Geographic Area in 2024
11.5.8 PerkinElmer, Inc Multiomics SWOT Analysis
11.5.9 PerkinElmer, Inc Recent Developments
11.6 Shimadzu Corporation
11.6.1 Shimadzu Corporation Corporation Information
11.6.2 Shimadzu Corporation Business Overview
11.6.3 Shimadzu Corporation Multiomics Product Features and Attributes
11.6.4 Shimadzu Corporation Multiomics Revenue and Gross Margin (2020-2025)
11.6.5 Shimadzu Corporation Recent Developments
11.7 Bruker
11.7.1 Bruker Corporation Information
11.7.2 Bruker Business Overview
11.7.3 Bruker Multiomics Product Features and Attributes
11.7.4 Bruker Multiomics Revenue and Gross Margin (2020-2025)
11.7.5 Bruker Recent Developments
11.8 QIAGEN
11.8.1 QIAGEN Corporation Information
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Multiomics Product Features and Attributes
11.8.4 QIAGEN Multiomics Revenue and Gross Margin (2020-2025)
11.8.5 QIAGEN Recent Developments
11.9 Agilent Technologies, Inc.
11.9.1 Agilent Technologies, Inc. Corporation Information
11.9.2 Agilent Technologies, Inc. Business Overview
11.9.3 Agilent Technologies, Inc. Multiomics Product Features and Attributes
11.9.4 Agilent Technologies, Inc. Multiomics Revenue and Gross Margin (2020-2025)
11.9.5 Agilent Technologies, Inc. Recent Developments
11.10 BGI Genomics
11.10.1 BGI Genomics Corporation Information
11.10.2 BGI Genomics Business Overview
11.10.3 BGI Genomics Multiomics Product Features and Attributes
11.10.4 BGI Genomics Multiomics Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 MultiomicsIndustry Chain Analysis
12.1 Multiomics Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Multiomics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Multiomics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Multiomics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Multiomics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Multiomics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Multiomics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Multiomics Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Multiomics Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Multiomics Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Multiomics by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiomics as of 2024)
Table 11. Global Multiomics Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Multiomics Companies Headquarters
Table 13. Global Multiomics Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Multiomics Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Multiomics Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Multiomics Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Multiomics Revenue by Application (2026-2031) & (US$ Million)
Table 21. Multiomics High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Multiomics Growth Accelerators and Market Barriers
Table 25. North America Multiomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Multiomics Growth Accelerators and Market Barriers
Table 27. Europe Multiomics Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Multiomics Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Multiomics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Multiomics Investment Opportunities and Key Challenges
Table 31. Central and South America Multiomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Multiomics Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Multiomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. BD Corporation Information
Table 35. BD Description and Major Businesses
Table 36. BD Product Features and Attributes
Table 37. BD Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. BD Revenue Proportion by Product in 2024
Table 39. BD Revenue Proportion by Application in 2024
Table 40. BD Revenue Proportion by Geographic Area in 2024
Table 41. BD Multiomics SWOT Analysis
Table 42. BD Recent Developments
Table 43. Thermo Fisher Scientific, Inc. Corporation Information
Table 44. Thermo Fisher Scientific, Inc. Description and Major Businesses
Table 45. Thermo Fisher Scientific, Inc. Product Features and Attributes
Table 46. Thermo Fisher Scientific, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Thermo Fisher Scientific, Inc. Revenue Proportion by Product in 2024
Table 48. Thermo Fisher Scientific, Inc. Revenue Proportion by Application in 2024
Table 49. Thermo Fisher Scientific, Inc. Revenue Proportion by Geographic Area in 2024
Table 50. Thermo Fisher Scientific, Inc. Multiomics SWOT Analysis
Table 51. Thermo Fisher Scientific, Inc. Recent Developments
Table 52. Illumina, Inc Corporation Information
Table 53. Illumina, Inc Description and Major Businesses
Table 54. Illumina, Inc Product Features and Attributes
Table 55. Illumina, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Illumina, Inc Revenue Proportion by Product in 2024
Table 57. Illumina, Inc Revenue Proportion by Application in 2024
Table 58. Illumina, Inc Revenue Proportion by Geographic Area in 2024
Table 59. Illumina, Inc Multiomics SWOT Analysis
Table 60. Illumina, Inc Recent Developments
Table 61. Danaher (Beckman Coulter) Corporation Information
Table 62. Danaher (Beckman Coulter) Description and Major Businesses
Table 63. Danaher (Beckman Coulter) Product Features and Attributes
Table 64. Danaher (Beckman Coulter) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Danaher (Beckman Coulter) Revenue Proportion by Product in 2024
Table 66. Danaher (Beckman Coulter) Revenue Proportion by Application in 2024
Table 67. Danaher (Beckman Coulter) Revenue Proportion by Geographic Area in 2024
Table 68. Danaher (Beckman Coulter) Multiomics SWOT Analysis
Table 69. Danaher (Beckman Coulter) Recent Developments
Table 70. PerkinElmer, Inc Corporation Information
Table 71. PerkinElmer, Inc Description and Major Businesses
Table 72. PerkinElmer, Inc Product Features and Attributes
Table 73. PerkinElmer, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. PerkinElmer, Inc Revenue Proportion by Product in 2024
Table 75. PerkinElmer, Inc Revenue Proportion by Application in 2024
Table 76. PerkinElmer, Inc Revenue Proportion by Geographic Area in 2024
Table 77. PerkinElmer, Inc Multiomics SWOT Analysis
Table 78. PerkinElmer, Inc Recent Developments
Table 79. Shimadzu Corporation Corporation Information
Table 80. Shimadzu Corporation Description and Major Businesses
Table 81. Shimadzu Corporation Product Features and Attributes
Table 82. Shimadzu Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Shimadzu Corporation Recent Developments
Table 84. Bruker Corporation Information
Table 85. Bruker Description and Major Businesses
Table 86. Bruker Product Features and Attributes
Table 87. Bruker Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Bruker Recent Developments
Table 89. QIAGEN Corporation Information
Table 90. QIAGEN Description and Major Businesses
Table 91. QIAGEN Product Features and Attributes
Table 92. QIAGEN Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. QIAGEN Recent Developments
Table 94. Agilent Technologies, Inc. Corporation Information
Table 95. Agilent Technologies, Inc. Description and Major Businesses
Table 96. Agilent Technologies, Inc. Product Features and Attributes
Table 97. Agilent Technologies, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Agilent Technologies, Inc. Recent Developments
Table 99. BGI Genomics Corporation Information
Table 100. BGI Genomics Description and Major Businesses
Table 101. BGI Genomics Product Features and Attributes
Table 102. BGI Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. BGI Genomics Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Multiomics Product Picture
Figure 2. Global Multiomics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Single-cell Multiomics Product Picture
Figure 4. Bulk Multiomics Product Picture
Figure 5. Global Multiomics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Cell Biology
Figure 7. Oncology
Figure 8. Neurology
Figure 9. Immunology
Figure 10. Others
Figure 11. Multiomics Report Years Considered
Figure 12. Global Multiomics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Multiomics Revenue (2020-2031) & (US$ Million)
Figure 14. Global Multiomics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Multiomics Revenue Market Share by Region (2020-2031)
Figure 16. Global Multiomics Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Single-cell Multiomics Revenue Market Share by Player in 2024
Figure 19. Bulk Multiomics Revenue Market Share by Player in 2024
Figure 20. Global Multiomics Revenue Market Share by Type (2020-2031)
Figure 21. Global Multiomics Revenue Market Share by Application (2020-2031)
Figure 22. North America Multiomics Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Multiomics Revenue (US$ Million) in 2024
Figure 24. North America Multiomics Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Multiomics Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Multiomics Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Multiomics Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Multiomics Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Multiomics Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Multiomics Revenue (US$ Million) in 2024
Figure 31. Europe Multiomics Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Multiomics Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Multiomics Revenue (2020-2031) & (US$ Million)
Figure 34. France Multiomics Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Multiomics Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Multiomics Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Multiomics Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Multiomics Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Multiomics Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Multiomics Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Multiomics Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Multiomics Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Multiomics Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Multiomics Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Multiomics Revenue (2020-2031) & (US$ Million)
Figure 46. India Multiomics Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Multiomics Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Multiomics Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Multiomics Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Multiomics Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Multiomics Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Multiomics Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Multiomics Revenue (US$ Million) in 2024
Figure 54. Central and South America Multiomics Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Multiomics Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Multiomics Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Multiomics Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Multiomics Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Multiomics Revenue (US$ Million) in 2024
Figure 60. South America Multiomics Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Multiomics Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Multiomics Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Multiomics Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Multiomics Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Multiomics Revenue (2020-2025) & (US$ Million)
Figure 66. Multiomics Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
